News & Updates

Show Multimedia Only
Maintenance niraparib a boon in advanced ovarian cancer

Maintenance niraparib a boon in advanced ovarian cancer

24 Jun 2022 byJairia Dela Cruz

Use of niraparib in the maintenance setting appears to minimize the risk of progression in advanced ovarian cancer patients, with surgical timing having little to no effect on the drug’s efficacy, as shown in a post hoc analysis of the phase III PRIMA/ENGOT-OV26/GOG-3012 study.

Maintenance niraparib a boon in advanced ovarian cancer

24 Jun 2022
KangDuo Surgical Robot-01 system feasible for robot-assisted radical prostatectomy

KangDuo Surgical Robot-01 system feasible for robot-assisted radical prostatectomy

24 Jun 2022
Colorectal cancer alters gut microbiome

Colorectal cancer alters gut microbiome

24 Jun 2022 byTristan Manalac

Patients with colorectal cancer (CRC) have a substantially altered gut microbiome, characterized by changes in bacterial composition, according to a recent Singapore study. Of note, these alterations persist even after surgery.

Colorectal cancer alters gut microbiome

24 Jun 2022